This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by HINTZ, R.L. Articles by KEMP, S.F. Search for Related Content PubMed PubMed Citation Articles by HINTZ, R.L. Articles by KEMP, S.F.

Plasma Somatomedin-Binding Proteins in Hypopituitarism: Changes during Growth Hormone Therapy^*

R.L. HINTZ, F. LIU, R.G. ROSENFELD and S.F. KEMP

Department of Pediatrics, Stanford University Medical Center Stanford California 94305

The somatomedin (SM) peptides axe carried in plasma complexed to specific SM-binding proteins (SMBPs). In addition to the SMBP in the complex, there is an unsaturated SMBP in plasma in which the SMBP is not occupied by SMs. We have compared levels of unsaturated SMBP in 7 normal adults to those in 21 children with GH deficiency before and during treatment with hGH (0.1 U/kg-day) for 4 days. In addition, the SM-C/insulin-like growth factor I (IGF-I) content of each plasma was measured by RIA. There was a significant (P < 0.01) difference in unsaturated SMBP levels between normal controls (17.8 ± 0.8% bound/20µl) and untreated hypopituitary patients (27.8 ± 2.% bound/20 µl). Thus, a lower SM-C/IGF-I content was associated with a higher unsaturated SMBP level. Furthermore, there was a significant negative correlation between SM-C/IGF-I content and unsaturated SMBP in untreated hypopituitary patients (r = 0.73; P < 0.0001). Treatment with hGH normalized the mean unsaturated SMBP level in hypopituitary patients within 2 days. Full displacement curves and Scatchard analysis showed that the increased unsaturated SMBP level in hypopituitary plasma was entirely due to an increased affinity (8.4 x 0.9 x 10–¹⁰ M) compared to normal (2.3 X 0.2 x 10–⁹ M). A higher affinity form of unsaturated SMBP is uniquely present in hypopituitarism and disappears with hGH treatment. The measurement of this unsaturated SMBP mirrors the SM peptide content.

^* This work was supported by NIH Grants AM-21058 and AM-24085.

To whom requests for reprints should be addressed.

Received November 17, 1980.

This article has been cited by other articles:

				D. R. Powell, S. K. Durham, F. Liu, B. K. Baker, P. D. K. Lee, S. L. Watkins, P. G. Campbell, E. D. Brewer, R. L. Hintz, and R. J. Hogg The Insulin-Like Growth Factor Axis and Growth in Children with Chronic Renal Failure: A Report of the Southwest Pediatric Nephrology Study Group J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1654 - 1661. [Abstract] [Full Text]

				P. D. K. Lee, S. K. Durham, V. Martinez, O. Vasconez, D. R. Powell, and J. Guevara-Aguirre Kinetics of Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Responses to a Single Dose of Growth Hormone J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2266 - 2274. [Abstract] [Full Text] [PDF]

				A. Heding, R. Gill, Y. Ogawa, P. De Meyts, and R. M. Shymko Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3 J. Biol. Chem., June 14, 1996; 271(24): 13948 - 13952. [Abstract] [Full Text] [PDF]